Vera Therapeutics Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Marshall Fordyce
Chief executive officer
US$3.4m
Total compensation
| CEO salary percentage | 17.1% |
| CEO tenure | 8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.3yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect
Jan 25Vera Therapeutics: Under The Radar IgAN Player Has Much To Prove
Sep 06Vera Therapeutics GAAP EPS of -$0.55 beats by $0.17
Aug 10Companies Like Vera Therapeutics (NASDAQ:VERA) Are In A Position To Invest In Growth
Feb 16
Vera: Biotech With 3 Mid-Stage Programs With Potential For Success
Jan 19Vera Therapeutics: Surprising Pivot To A Kidney Disease Drug Looks Like A Long Shot
Jan 07We Think Vera Therapeutics (NASDAQ:VERA) Can Afford To Drive Business Growth
Oct 25Vera Therapeutics soars 16% on three new favorable view from analysts
Jun 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$94m |
| Dec 31 2023 | US$3m | US$586k | -US$96m |
| Sep 30 2023 | n/a | n/a | -US$103m |
| Jun 30 2023 | n/a | n/a | -US$107m |
| Mar 31 2023 | n/a | n/a | -US$102m |
| Dec 31 2022 | US$4m | US$551k | -US$89m |
| Sep 30 2022 | n/a | n/a | -US$73m |
| Jun 30 2022 | n/a | n/a | -US$56m |
| Mar 31 2022 | n/a | n/a | -US$45m |
| Dec 31 2021 | US$1m | US$479k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$59m |
| Jun 30 2021 | n/a | n/a | -US$55m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$3m | US$360k | -US$53m |
Compensation vs Market: Marshall's total compensation ($USD3.43M) is below average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: Marshall's compensation has been consistent with company performance over the past year.
CEO
Marshall Fordyce (48 yo)
8yrs
Tenure
US$3,429,733
Compensation
Dr. Marshall W. Fordyce, M.D. is Founder of Vera Therapeutics, Inc. and has been its President, Chief Executive Officer and Director since May 2016. From April 2011 to July 2016, Dr. Fordyce held a number...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8yrs | US$3.43m | 0.42% $ 10.3m | |
| Chief Financial Officer | 2.8yrs | US$1.76m | 0.041% $ 1.0m | |
| Senior VP of Finance & Chief Accounting Officer | 3yrs | no data | 0.039% $ 957.1k | |
| VP & Head of Legal | 2.3yrs | no data | no data | |
| VP & Head of Human Resources | 2.3yrs | no data | no data | |
| Senior Vice President of Development Operations | 4.2yrs | no data | no data | |
| Chief Business Officer | 6.8yrs | no data | no data | |
| Senior VP and Head of Product Development & Manufacturing | 1.4yrs | no data | no data | |
| Senior Vice President of Medical Affairs | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Chief Development Officer | less than a year | no data | no data |
2.3yrs
Average Tenure
50yo
Average Age
Experienced Management: VERA's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 8yrs | US$3.43m | 0.42% $ 10.3m | |
| Independent Director | 3.6yrs | US$153.63k | 0% $ 0 | |
| Independent Chairman of the Board | 2yrs | US$187.13k | 0% $ 0 | |
| Independent Director | 3.6yrs | US$155.63k | 0% $ 0 | |
| Independent Director | 7.9yrs | US$153.13k | 0% $ 0 | |
| Independent Director | 4.1yrs | US$160.63k | 0% $ 0 | |
| Independent Director | 7yrs | US$154.63k | 0.032% $ 786.0k | |
| Independent Director | 2.4yrs | US$152.04k | 0% $ 0 |
3.8yrs
Average Tenure
59yo
Average Age
Experienced Board: VERA's board of directors are considered experienced (3.8 years average tenure).